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Presence of oral pathogenic microorganisms in atheroma and thrombus of patients with 
atherosclerosis and myocardial infarction 
 
Summary  
Introduction: Periodontal pockets harbor more than 400 different bacterial species. The aims of 
this study were to establish new links between periodontitis and atherosclerosis by quantitative and 
qualitative assessment of periodontal pathogens Аggregatibacter actinomycetemcomitans (Aa), 
Porphyromonas gingivalis (Pg), Prevotella intermedia (Pi), Tannerella forsythi (Tf) and 
Treponema denticola (Td) in patient’s mouth and blood vessel. 
Material and Methods: 100 patients with periodontitis and atherosclerosis were included in the 
study, divided into 6 groups according to the localization of atheromas and into 2 groups in relation 
to their age (below and over 60). 13 thrombi from patients with myocardial infarction were 
analyzed for the presence of oral bacteria and CMV. Pathogen presence and their total load were 
determined by PCR and real-time quantitative PCR, respectively, and statistically analyzed. 
Results: 91% of oral samples and 65% of samples of atherosclerotic plaques were positive for at 
least one of the tested microorganism. Decreasing frequencies of bacteria in oral vs. artery 
specimens were: Tf (76%:53%), Pi (71%:31%), Pg (60%:38%), Aa (39%:14%) and Td (21%:6%). 
and their ratio was as follows: Tf 1.4, Pg 1.6, Pi 2.3, Aa 2.8 and Td 3.5. Oral bacteria were the most 
frequent in coronary arteries. There was no statistical difference in the load of microorganisms 
between younger and older patients, but Pi and Aa were less frequent in older patients. CMV was 
more frequent in thrombi than in atheromas.  
Conclusion: Oral pathogens were found at high frequency in atheroma plaques and thrombi, with a 
slightly changed bacterial composition compared to oral biofilm. Patient’s age and the distance of a 
given blood vessel from the mouth influenced microbiological findings.  
 
Keywords: oral pathogenic microorganisms, periodontal disease, atherosclerosis, age, PCR, real-
time PCR 
Scientific field: Biology 






Prisustvo oralnih patogenih mikroorganizama u ateromu i trombu pacijenata sa 
aterosklerozom i infarktom miokarda 
SAŽETAK  
 
Uvod: Parodontalni džepovi sadrže više od 400 različitih bakterijskih vrsta i sa ovom studijom se 
želela ustanoviti nova veza između parodontopatije i ateroskleroze koristeći kvalitativno i 
kvantitativno određivanje prisustva parodontopatogena Aggregatibacter actinomycetemcomitans 
(Aa), Porphyromonas gingivalis (Pg), Prevotella intermedia (Pi), Tannerella forsythi (Tf) i 
Trepondema denticola (Td)  u usnoj duplji i krvnim sudovima pacijenata. 
Materijal i metode: U ispitivanje je bilo uključeno 100 pacijenata sa parodontopatijom i 
aterosklerozom, podeljenih u 6 grupa u skladu sa lokalizacijom ateroma i u 2 grupe u odnosu na 
starost pacijenata (ispod i iznad 60 godina). Analizirano je i 13 trombova od pacijenata sa infarktom 
miokarda na prisustvo oralnih bakterija i CMV. Detekcija patogena i ukupno opterećenje 
mikroorganizmima određeni su PCR-om (običnim, odnosno kvantitativnim) a dobijeni podaci su 
statistički obrađeni. 
Rezultati: Ispitani mikroorganizmi su bili visoko zastupljeni kako u gingivalnom tako i u 
aterosklerotskom plaku. Redosled opadajućih učestalosti bakterija u oralnim uzorcima nasuprot 
ateromima bio je: Tf (76%: 53%), Pi (71%: 31%), Pg (60%: 38%), Aa (39%: 14%) i Td (21%: 6%), 
a njihov odnos je bio sledeći: Tf 1,4, Pg 1,6, Pi 2,3, Aa 2,8 i Td 3,5. Oralni patogeni bili su najčešći 
u koronarnim arterijama. Nije bilo značajne razlike u ukupnom sadržaju mikroorganizama između 
mlađih i starijih pacijenata, ali Pi i Aa su bili češći kod mlađih pacijenata. CMV je bio češći u 
trombovima nego u ateromima. 
Zaključak: Oralni patogeni su bili učestali i u ateromima i u trombovima, sa blago izmenjenim 
sastavom bakterijske zajednice u odnosu na zajednicu u oralnom biofilmu. Mikrobiološki nalaz 
zavisio je od starosti pacijenta i udaljenosti krvnog suda od usne duplje. 
 
Ključne reči: oralni patogeni mikroorganizmi, parodontitis, ateroskleroza, starenje, PCR, PCR u 
realnom vremenu 
Naučna oblast: Biologija 
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Oral health is continuously classified as one of the most important public health issues globally. 
Even with substantial improvements of our knowledge related to oral health and cures of oral 
conditions over the past decades, gingivitis and periodontitis are still among the most prevalent 
bacterial infections in humans. There has been a considerable rise in the number of people 
preserving more of their natural teeth, over the past half century; hence, this ever more dentate 
population is at higher risk of developing periodontal diseases.  
The oral cavity is a noteworthy contributor to total burden of infection and inflammation and, 
consequently to overall health. The mouth harbors more than 700 different bacterial species while 
periodontal pockets contain more than 400 (Inaba & Amano 2010).  
Association between oral infections and systemic diseases has been suspected for centuries. The 
effect of oral health on the rest of the body was proposed by Assyrians as early as the 7th century 
B.C. (Malhotra & Parkash 2013), and historically, various explanations have been given as to the 
origin of atherosclerosis, including issues related to oral health. One hundred years ago, “focal 
infection” hypothesis postulated that caries was etiologically connected to various  pathologies in 
distant human organs (Batty et al. 2018; Pizzo et al. 2010) More recently, periodontitis has been 
linked to the development of atherosclerosis (Inaba & Amano 2010); (Pihlstrom et al. 2005). This 
is still a matter of debate, with the number of various types of studies, addressing the connection 
between periodontal disease and coronary heart disease, increasing exponentially in the last 
decades. Several review papers (Batty et al. 2018; Janket et al. 2003; Lockhart et al. 2012) have 
shown that poor oral health is related to increased risk of cardiovascular diseases. The basic 
explanation for this relationship  lies in the evidence that oral infections are linked to increased 
systemic inflammation (Batty et al. 2018; Davé & Van Dyke 2008), which in turn is considered to 
be involved in the etiology of cardiovascular disease  (Batty et al. 2018; Davé & Van Dyke 2008). 
The high occurrence of coronary heart disease, a leading cause of morbidity burden, if linked with 
periodontal disease (Batty et al. 2018; Naghavi et al. 2015) could markedly be reduced by treating 
periodontal disease more methodically and aggressively.  
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1.1. Cardiovascular Disease (CVD) 
The leading cause of death worldwide is cardiovascular disease (CVD)  and it is accountable 
for over 17.3 million deaths annually (Ellis et al. 2017; Mozaffarian et al. 2015; Stringhini et al. 
2012; Lopez et al. 2006). However, quite different trends in CVD mortality are observed in 
different populations. In high-income countries, CVD mortality has declined progressively over the 
past three decades (Stringhini et al. 2012; Levi et al. 2002). This has been due to positive changes 
in population lifestyle, i.e. to decreased levels of major cardiovascular risk factors such as tobacco 
use, hypertension, unhealthy diets and physical inactivity. In parallel there has been an 
improvement in patients treatment  (Stringhini et al. 2012; (Unal et al. 2004). While the CVD 
epidemic is receding in high-income countries, CVD mortality rates tend to be higher in many low 
and middle-income countries (up to 300-600 CVD deaths per 100,000 population), than in western 
countries (Bovet & Paccaud 2012). 
 
In low and middle-income countries (LMICs), the total CVD 
burden is predicted to increase due to aging populations and most probably to detrimental lifestyle 
changes associated with socioeconomic development and urbanization (Stringhini et al. 2012; 
Yusuf et al. 2004; Reddy & Yusuf 1998). Prevention and control of atherosclerosis include 
adequate medications, healthy diet, physical activity, etc. Establishment of microbial involvement 
in this disease might additionally lead to new non-invasive intervention strategies.  
CVD refers to a group of disorders of the heart and blood vessels and includes high blood 
pressure, coronary heart disease (CHD), congestive heart failure, stroke, and myocardial infarction. 
These conditions lie approximately behind 40% of all deaths worldwide, with atherosclerosis being 
the principal etiologic factor in the majority of cases (Inaba & Amano 2010; Seymour et al 2009).   
Atherosclerosis has been defined as a progressive disease that causes focal thickening of large 
to medium-sized muscular and large elastic arteries. Atherosclerosis is also the most common cause 
of coronary artery disease (CAD) (Pucar et al. 2007; Beck et al 2000; Becker et al. 2001). 
Factors, such as smoking, diabetes mellitus and periodontitis have been shown to be related to the 
development of atherosclerosis.   
During the development of atherosclerosis plaques build up inside arteries. Arterial plaque 
consists of cholesterol, lipids, fibrin, calcium, macrophages (foam cells), and other material related 
to inflammation (Ellis et al. 2017; Maton, et al. 1993) (Figure 1). Over time, plaque hardens and 
narrows arteries leading to heart attack, stroke, or even death. Atherosclerotic plaque formation, 
particularly in coronary artery and carotid artery diseases have been the subject of extensive studies 
(Ellis et al. 2017; Tedgui & Mallat 1999). Recent molecular studies have established an 
association of pathogenic bacteria with arterial disease (Ellis et al. 2017; Lanter et al. 2014; 
Anand et al. 2014). The recognised link between poor oral health and myocardial infarction (MI) 
(Chukkapalli et al. 2015; Mattila et al. 1989) prompted a high interest for the relationship 
between dental infections and CVD. In particular, periodontitis and microorganisms of the dental 
biofilm have been associated with arterial disease (Ellis et al. 2017;  Soto-Barreras et al. 2012). In 
addition, oral microorganisms can be a serious medical threat for persons with already predisposing 
heart conditions such as pacemaker implant, heart valve problems, etc (Chukkapalli et al. 2015; 
Ito, H.-O. 2006).  
Studies on animal models and in vitro experiments determined likely pathogenetic mechanisms 
underlying the relationship between atherosclerosis and periodontal disease. Namely, bacteria from 
subgingival plaque along with their endotoxins possibly will disseminate/shed into systemic 
circulation via damaged gums and have impact on distant organs (Chukkapalli et al. 2015; 
Hirschfeld & Kawai 2015). One of the central issues regarding the relationship between oral 
health and CHD, are confounding factors (Batty et al. 2018; Lockhart et al. 2012). That is, 
etiological factors associated with both periodontitis and CHD, such as smoking, alcohol intake, 
diabetes mellitus provide an alternative explanation for the association. In etiologically oriented 
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randomized controlled trials, investigators typically control for candidate confounding variables in 
an effort to identify ‘independent' effects (Batty et al. 2018; Lockhart et al. 2012). Another, more 
powerful approach should be to examine the tooth loss - coronary heart disease tie in subjects who 
do not drink, or smoke, or are free of diabetes, i.e. free of confounding factors.  
Normally, the spread of oral pathogenic microorganisms into bloodstream should be limited by 
the innate host defense system in the oral cavity. In addition, by maintaining intact the gingival 
epithelium the spread of oral bacteria should be restrained (Inaba & Amano 2010; Milward et al. 
2007). Despite this protection exerted by the oral epithelium, it has been shown that oral pathogens 
can invade blood vessels. Interestingly, although DNA from oral bacteria has been found in 
atherosclerotic plaques, the contribution of these bacteria to plaque formation remained 
questionable for a long period of time, and some controversies in this regard are still present.  
 
 




1.2. Periodontal disease 
Teeth are surrounded by gingiva and the space between the tooth and gingiva is called gingival 
sulcus and is lined by sulcular epithelium. Within the sulcus, epithelia and crown enamel form 
specific surfaces inhabited by oral microorganisms. In this specific niche, different bacteria thrive, 
forming a biofilm termed dental plaque. Primary colonizers in the sulcus are streptococci, for 
instance Streptococcus mutans, S. sanguis, S. oralis, Neisseria sp., and others. These 
microorganisms diminish the local availability of O2 and hence create a suitable environment for 
obligate anaerobes that will then invade the gingival sulcus and proliferate there. The first colonizer 
of the gingival sulcus, beside diminishing O2, also provide the substrate for bacteria that come later 
on, which are mostly anaerobic (Fusobacterium nucleatum, Veillonella sp. or actinomycetes –for 
instance Actinomyces odontolyticus and A. naeslundii, etc.), and form an adequate background for 
their attachement (Chukkapalli et al. 2015; Rickard et al. 2003). It is estimated that oral biofilm 
bacteria exceed 400 species (Chukkapalli et al. 2015; Moore & Moore 2000).  
Oral biofilm composition is under the influence of many elements among others O2 supply, 
oral hygiene and oral pH, dietary habits and, importantly, the complex relationship between 
microorganisms. Supragingival and subgingival, microbial contents are significantly different. The 
subgingival plaque of healthy persons is mostly formed by streptococci, facultatively anaerobic 
actinomycetes, and F. nucleatum (Chukkapalli et al. 2015; Moore & Moore 2000) while in the 
case of gingivitis and periodontitis there is a shift in the microbiome toward predominance of 
strictly anaerobic species (Chukkapalli et al. 2015).  
Periodontal diseases, both periodontitis and gingivitis, represent the most frequent dental 
diseases in human after caries (Bartova et al. 2014; Milasin et al. 2011; Leong et al. 2014). The 
first records on the disease date back to the 9th and 10th centuries A.D. with Arab physicians 
already relating the condition to soft plaque on teeth (Bartova et al. 2014). Indeed, bacterial plaque, 
a gluey, colourless film that constantly forms on teeth, is the main cause of periodontal disease 
(Inaba & Amano 2010). 
Gingivitis is the most prevalent and common form of periodontal disease among children and 
adolescents. It is important to note that it is a reversible pathology. Gingivitis appears as gum 
swelling, redness, bleeding during tooth-brushing, and may evolve into periodontitis with, in turn, 
more damage to periodontal tissues and alveolar bone.  
Periodontitis is a chronic infection involving teeth supporting tissues in the jaws (both soft 
and hard tissues). In periodontitis, following the reduction of periodontal tissues, teeth (one or 
many) become mobile and can be exfoliated (Leong et al. 2014). It is a multifactorial disease and 
among important elements, besides the presence of pathogenic bacteria, are genetic predisposition 
and the quality of host immunological reaction to pathogenic microorganisms (Bartova et al. 2014; 
Milasin et al. 2011) Microorganisms of the subgingival plaque, submerged in the extracellular 
matrix of the sulcular epithelium, establish complex relationships between each other and host cells 
(Chukkapalli et al. 2015; Gibbons 1989). Periodontopathogens have the capacity to enter sulcular 
epithelium via endocytosis  (Chukkapalli et al. 2015; Meyer & Lippmann 1996) and this 
invasion is accompanied by the release of proinflammatory cytokines. Bacterial surface molecules, 
such as lipopolysaccharides, stimulate the production of cytokines and other mediators of  
inflammation that will then induce the synthesis of matrix metalloproteinases, enzymes crucial for 
extracellular matrix remodelling/bone destruction. Ulcerated gingival epithelium releases different 
chemical mediators such as interleukins, prostaglandin E2, tumor necrosis factor alpha, etc. that 
will attract neutrophils and macrophages to the lesion site. In physiological conditions, with a 
healthy immune system, bacterial insult can be maintained under control with no damage to the host 
tissue. However, if there is an increased bacterial burden or inadequate immune response, the acute 
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periodontal inflammation becomes chronic. Additional mediators are then synthesized and more 
cells of the immune system are recruited. The prolonged state of inflammation will induce bone 
destruction by osteoclasts. The basic processes occuring during the development of periodontal 


















Figure 2. The basic processes occuring during the development of periodontal disease 
(https://www.dental-nursing.co.uk/features/periodontal-disease-and-systemic-health). 
 
Oral pathogenic microorganisms show a remarkable capacity for survival within the invaded 
cells. They inactivate antimicrobial factors, disable immune cells, and stimulate processes of host 
tissue degradation (Chukkapalli et al. 2015; Amano 2007).  
The deepening of the sulcus, triggered by oral biofilm expansion, local inflammation, and 
destruction of the gum attachment result in the development of periodontal pockets, site of choice 
for pathogens accumulation. There, bacteria will exacerbate the inflammation of teeth supporting 
tissues (Chukkapalli et al. 2015; Smalley 1994). In periodontal disease, the fiber attachment is 
reduced or missing, and the oral biofilm grows apically along the root, initially provoking 




Figure 3. Schematic representation of healthy gum versus gum of a person with periodontal disease  
(https://toothlessmind.wordpress.com) 
 
Periodontal pockets release crevicular fluid, an exudate that contains bacterial degradation 
products and metabolites, cell debris, inflammatory molecules, enzymes, etc. (Chukkapalli et al. 
2015; Subrahmanyam & Sangeetha 2003). The inflamed periodontal tissue is recurrently (or 
persistently) bleeding allowing microorganisms to enter the bloodstream (Pucar et al. 2007). 
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1.3. Periodontitis-related microorganisms  
Periodontitis is mostly the result of gum colonization by Gram-negative anaerobic bacteria. No 
single bacterial species has been designated as the primary pathogen; instead, periodontal disease is 
considered to be a polymicrobial disease. Porphyromonas gingivalis, Treponema denticola, 
Aggregatibacter actinomycetemcomitans, Prevotella intermedia and Tannerella forsythia are 
among those microorganisms strongly implicated in the onset of periodontitis (Sharma 2010;  
Socransky et al. 1998).  
Porphyromonas gingivalis (Figure 4) is a Gram-negative, not motile, rod-shaped oral anaerobe 
belonging to the phylum bacteroidetes. It regarded as one of the major pathogens implicated in the 




Figure 4.  P. gingivalis under scanning electron microscope (SEM). 
Mary e. Davey, and Margaret j. Duncan j. Bacteriol. 2006; doi:10.1128/jb.01685- 05 
  
Properties and more specifically the pathogenicity factors of Porphyromonas gingivalis, 
which lead to the destruction of tissues surrounding and supporting the teeth, are responsible for the 
initiation of inflammatory and immune processes (Mysak et al. 2014; Kinane et al 2008). 
Porphyromonas gingivalis uses a range of virulence factors that disturb the innate immune system 
and the host’s response to inflammation. It invades periodontal tissues and escapes host defense 
machinery (Mysak et al. 2014; Bostanci & Belibasakis 2012). P. gingivalis activates cellular 
autophagy and, while suppressing apoptosis, it provides an optimal replicative niche. The severe 
inflammatory conditions existing in periodontal pockets point to the remarkable ability of this 
bacterium to respond and adapt to oxidative stress (Mysak et al. 2014; Henry et al. 2012). 
Moreover, it is also clear that P. gingivalis has the capacity to avoid host immune response albeit 
not affecting the inflammatory response, which is beneficial for this and other periodontal 
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microorganisms (Mysak et al. 2014; Hajishengallis 2011). The inflammatory exudate is actually a 
source of indispensable nutrients. P. gingivalis is a keystone pathogen with a disproportionately 
huge consequence on its environment relative to its quantity, as it is present at relatively low 
colonization levels (Andjelkovic et al. 2015; Hajishengallis et al. 2012; Darveau 2009). P. 
gingivalis is a quantitatively minor constituent of human periodontitis-associated biofilms, 
opposing to the findings of early, culture-based, studies (Kumar et al. 2006; Doungudomdacha et 
al. 2000). The environment of P. gingivalis such as host-related factors or other bacteria that are 
auxiliary microorganisms that help P. gingivalis in terms of colonization and metabolic activities, 
plays an important role in its virulence (Hajishengallis & Lamont 2012). P. gingivalis virulence 
proteins such as gingipains, FimA fimbriae, lipid A phosphatase, HtrA protease, etc. have been 
found to be under the influence of environmental factors (Xie et al. 1997; Roy et al. 2006). 
 
Moreover, P. gingivalis (and other periodontal bacteria) metabolism in affected sites is considerably 





Tannarella forsythia (Figure 5) is an anaerobic Gram-negative bacterium belonging to the 
Cytophaga–Bacteroides family. T. forsythia is the only member of the genus Tannerella. This 
microorganism is linked to different forms of periodontal disease (gingivitis, chronic and aggressive 















Figure 5.  T. forsythia seen under transmission electron microscope (TEM). Biology, Medicine. 
Published in Journal of dental research 2011. DOI:10.1177/0022034510384622. 
 
In spite of considerable evidence connecting T. forsythia with the pathogenesis of 
periodontitis, this microorganism has not been extensively studied mostly due to the very 
demanding growth requirements in culture and relatively difficult genetic manipulations (Sharma 
2010; Honma et al. 2001). Experiments on animal models have clearly shown the virulence of T. 
forsythia; it caused alveolar bone loss in mice and rats (Sharma 2010; Sharma et al. 2005),  and 
this virulence potential was boosted during co-infection with other microorganisms. For instance, 
abscess development in animal models was increased when Fusobacterium nucleatum or P. 
gingivalis were in coinfection with T. forsythia. This bacterial partnership was also registered with 
respect to alveolar bone loss in rats, subsequent to oral infection with the red-complex bacteria (T. 
denticola, P. gingivalis and T. forsythia) (Sharma 2010). Probably, T. forsythia has a considerable 
impact on the virulence of concomitant pathogens. Several presumed virulence factors have been 
recognised in T. forsythia,  such as trypsin-like and PrtH proteases (Sharma 2010; Saito et al. 
1997; Grenier 1995), the sialidases SiaH and NanH (Brahaml & Moncla 1992; Sharma 2010; 
Zu et al. 2007) a leucine-rich repeat cell-surface-associated and secreted protein BspA, (Sharma 
2010; Sharma et al. 1998), a-D-glucosidase and N-acetyl-beta-glucosaminidase (Sharma 2010; 
Hughes et al. 2003), etc. T. forsythia surface lipoproteins activate host cells to discharge 
proinflammatory mediators and induce programmed cell death. It was also established that T. 
forsythia lipoproteins stimulate human gingival fibroblasts and monocytes to produce interleukin-6 
(IL-6) and tumor necrosis factor alpha (TNF alpha). Transcription factor nuclear factor-kappa B 
11 
(NF- κB) activation was shown to be responsible for cytokine synthesis by host cells (Sharma 
2010; Hasebe et al. 2004), and it has been proposed that T. forsythia lipoproteins are possibly 
involved in the pathogenesis of periodontal disease by inducing apoptosis.  
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Aggregatibacter actinomycetemcomitans (Figure 6) is a Gram-negative capnophilic, 
facultatively anaerobic, rod-shaped bacterium belonging to the Pasteurellaceae family 
and HACEK cluster group. The latter stands for Haemophilus parainfluenzae, H. aphrophilus, A. 
actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, and Kingella kingae. This 
organism was initially named  Actinobacillus actinomycetemcomitans, but Nørskov-Lauritsen and 
Kilian (2006) reclassified it as Aggregatibacter actinomycetemcomitans (Nørskov-Lauritsen & 
Kilian 2006; Hajishengallis et al. 2012). 
 
 
Figures 6. SEM micrograph of A. actinomycetemcomitans. Subgingival Microbes. (2015).   Atlas of 
Oral Microbiology, 67–93. doi:10.1016/b978-0-12-802234-4.00004-5 
 
A. actinomycetemcomitans is one the most important bacteria underlying juvenile, localized 
aggressive periodontitis. A. actinomycetemcomitans strains are divided into 5 serotypes,  from a to 
e, of different virulence potential (Gholizadeh et al. 2017). The niche of this organism is oral 
cavity, but it has also been isolated from patients with different infectious conditions, such as 
septicemia, endocarditis, pneumonia, skin infections, osteitis, etc. A. actinomycetemcomitans may 
be particularly pathogenic because of its ability to invade periodontal tissues.  The microorganism’s 
virulence is the consequence of several factors: factors that modulate the promotion of 
inflammation, factors that induce host tissue destruction, and factors that inhibit host tissue repair. 
Bacterial virulence products/components include exopolysaccharides, various exotoxins, along with 
leukotoxin and cytolethal distending poisonous substance, etc. 
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Prevotella intermedia (Figure 7) belongs to the group of black-pigmented, Gram-negative 
bacteria.  P. intermedia is typically related to periodontitis as it has been isolated from deep dental 
pockets (Gharbia et al. 1994; Yang et al. 2013).  
 
 
Figures 7.  SEM micrograph of P. intermedia. Subgingival Microbes. (2015). Atlas of Oral 
Microbiology, 67–93. doi:10.1016/b978-0-12-802234-4.00004-5. 
 
P. intermedia is regarded as a potent periodontal pathogen responsible for aggressive forms 
of the disease. However, it has also been found in periodontally healthy subjects. In early studies 
there was a certain confusion regarding P. intermedia and P. nigrescens, two closely related 
species, as they were considered as P. intermedia serotypes (serotype 1 and serotypes 2 or 3). 
Assignment to two separate species was done relatively recently (Riggio et al. 1998). Prevotella 
has been very often isolated from polymicrobial infections of the oral cavity, for instance from 
periapical lesions, periodontal disease related to pregnancy (Maeda et al. 1998), and HIV 
associated periodontal lesions (Murray et al. 1989). P. intermedia metabolites are known to initiate 
and promote oral diseases, both directly and indirectly. P. intermedia products and surface 
components induce strong immune response and consequent periodontal tissue damage. 
Interactions between fimbria of bacterial and lamellipodia of epithelial cells determine adhesion and 
invasion capability of P. intermedia. Strong bacterial bonding could be explained by stimulation of 
host cell lamellipodia by damage and inflammation. Due to this interaction, P. intermedia serves as 
a primary colonizer of oral keratinocytes and a fundament for secondary colonizers, such as P. 
gingivalis. This obligate anaerobe is resistant to many antibiotics, but as P. intermedia uses iron for 
its metabolic purposes, it has been shown that oral iron chelators could be a suitable agent for 
controlling its growth. 
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Treponema denticola (Figure 8) is a Gram-negative bacterium, belonging to spirochetes. It is 
an obligate anaerobe, highly proteolytic and motile, residing within the oral cavity and well adapted 
to survive in this quite specific niche. 
 
Figure 8. SEM micrograph of T. denticola. http://gbpusdchart.com/graph/Treponema+Denticola/ 
 
T. denticola is usually isolated from human periodontitis lesions and its involvement within 
the pathologic process and progression of periodontal disease has been well documented (Inagaki 
et al. 2016).  Porphyromonas, Tannerella , and Treponema form the so-called “red complex” and 
are regularly co-isolated from lesions of chronic periodontal disease (Socransky et al. 1998). So 
far, many virulence factors of T. denticola affecting host cells and tissues have been described. The 
major outer sheath macromolecule (MSM) induces innate immune responses through TLR2-
MyD88 (Szulc et al. 2015; Dashper et al. 2011), affects the migration of neutrophils via taxis, 
and additionally acts as a pore-forming toxin. Dentilisin, a Treponema surface chymotrypsin-like 
protease is another major virulence factor, allowing host epithelia invasion (Inagaki et al. 2016). 
 Interestingly, T. denticola could be detected within the epithelial cells at twenty-four hours 
following the infection. Epithelia invasion permits not only to evade host immune surveillance, but 
also to enter into deeper periodontal tissues.  
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1.4. Periodontitis-related atherogenesis  
Subgingival microorganisms in patients with periodontitis provide a major and persistent 
challenge to the host. A large number of studies have reported a relationship between periodontal 
disease and vascular disease, in agreement with all the studies implicating chronic infections in the 
pathogenesis of vascular disease (Desvarieux et al. 2015; Espinola-klein et al. 2015; Kario et al. 
2001). Periodontitis atherosclerosis syndrome (PAS) was described in the late 1990s and the 
number of articles devoted to PAS has increased every year, from only four articles in 1998 to 
almost 4000 at present (Bartova et al. 2014). The majority of initial studies linking the two 
conditions, relied on indirect measures, such as pocket depth and attachment loss, or dental indices, 
radiographic findings (bone loss), extent of tooth loss, etc (Desvarieux et al. 2015; Loesche et al. 
1998) The project named Vascular Disease Epidemiology Study and Oral Infections was 
specifically designed to study the hypothesis that periodontal infections accelerate the progression 
of carotid atherosclerosis and increase the incidence of stroke, myocardial infarction, and 
cardiovascular disease death (Desvarieux et al. 2015).
 
This study has shown a clear link between 
periodontitis and atherosclerosis. 
Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Aggregatibacter 
actinomycetemcomitans DNAs have been found in stenotic coronary artery plaque samples, 
aneurysmal wall and aneurysmal thrombus tissues (Inaba & Amano 2010; Ishihara et al. 2004; 
Iwai et al. 2005). It is postulated that pathogenic microorganisms from periodontal pockets, along 
with their products via discontinuous/ulcerated sulcular epithelium, enter into periodontal tissues 
and further on into circulation. This is followed by systemic  inflammation, with increased 
circulating cytokines and other inflammatory mediators (Inaba & Amano 2010; Seymour et al. 
2007; Caesar et al. 2010). It can reasonably be expected that this transient bacteremia accompanied 
with elevated inflammatory markers in patients with periodontitis can influence vascular disease 






Figure 9.  Schematic summary of different effects of oral inflammation on atherosclerosis (source: 
Aarabi G, Heydecke G, Seedorf U. Roles of Oral Infections in the Pathomechanism of 
Atherosclerosis. Int J Mol Sci. 2018 Jul 6;19(7))  
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Different experimental findings have generated different hypotheses of microorganisms’ 
effects on blood vessels. Higashi et al have demonstrated that in patients with periodontitis but 
without cardiovascular risk factors, endothelial dysfunction was present and was due to systemic 
inflammation and reduction of nitric oxide availability (Higashi et al. 2008). Other studies have 
suggested the involvement of endotoxins and antigens produced by periodontal microorganisms in 
the pathogenesis of endothelial dysfunction (Bartova et al. 2014; Eng et al. 2015; Maekawa et al. 
2010; Bhagat et al. 1996). Periodontopathogens have the capacity to up-regulate different chemo-
attractant and adhesion molecules of endothelial origin that lead to the attachment of leukocytes 
onto the surface of endothelial cells (Schochetman et al. 1988; Bovet & Paccaud 2012).   P. 
gingivalis, for instance, can induce overexpression of the endothelial monocyte chemo-attractant 
protein-1 (MCP-1) (Choi et al. 2005; Hussain et al. 2015). In gingival cells, it can also induce a 
significant increase of expression and release of endothelin-1, a vasoconstrictor associated with 
CVD (Ansai et al. 2002; Kebschull et al. 2010). Basically, most of the effects exerted by oral 
pathogenic microorganisms can be grouped into four putative mechanisms of atherogenesis: (1) 
low-level bacteremia which allows bacteria to enter the circulation and invade the blood vessels’ 
walls; (2) systemic inflammation caused by mediators released from the sites of oral inflammation 
into the blood stream; (3) autoimmunity to proteins resulting from host immune response to specific 
components of pathogenic bacteria; (4) pro-atherogenic effects of different toxins produced by oral 
pathogens. In other words, chronic infections can contribute to atherogenesis either by direct 
mechansims such as platelet aggregation, invasion of endothelial cells, endothelial injury, etc. 
or/and by indirect mechanisms such as the production of intracellular adhesion molecules, 
production of antibodies to lipopolysaccharides, production of cytokines and dysfunction of the 
immune system (Buhlin et al. 2009). 
Although bacterial infections are considered to be the most important, when dealing with the 
role of oral inflammation in the etiology of atherosclerosis, there are however studies pointing also 
to the involvement of viral infections in atherogenesis. Herpes simplex virus (HSV) has been 
proposed in 1970s as a possible causative agent in the development of atherosclerosis in 
experimental animals (Fabricant et al. 1978). Another member of the herpesviridae family, 
cytomegalovirus (CMV) has also been implicated. Cytomegalovirus, which causes a lifelong 
infection, belongs to the subfamily Betaherpesvirinae. CMV has a high prevalence in the human 
population (55-100%); the marked variation in its prevalence is mainly due to differences in 
socioeconomic and geographical factors. Primary infection and reinfection of adults occur at higher 
rates among those in touch with young children within the home, daycare centers and colleges. 
Children seem to be a very important for CMV shedding, with rates of shedding peaking at 1-2 
years (Amin et al. 2018). Human Cytomegalovirus may be implicated in the pathogenesis of 
periodontal disease as a direct result of viral infection or as a consequence of herpes viral-bacterial 
co-infection, when virally induced impairment of local host defense favors the overgrowth of 
pathogenic bacteria. Recent studies have confirmed that destruction of periodontal tissues may be 
associated with the coexistence of Epstein-Barr and CMV and periodontal bacterial pathogens 
(Jakovljevic et al. 2016). Thus, oral infections can serve as viral reservoirs and local tissue 
destruction may lead to virus transfer to blood vessels, along with bacteria. 
Many serological and molecular studies have determined the association between CMV and 
atherosclerosis. More precisely, CMV infection of endothelial cells, leading to endothelial cells 
damage and metabolic alterations, has been shown to play an important role in the development of 
atherosclerosis. The development of atherosclerosis related to viral infection, by its consequences in 
terms of host reaction, resembles to the events caused by bacteria, i.e. it is closely related to 
inflammatory processes with the production of interleukins (IL-1, Il− 6, Il− 8, etc.), cytokines 
(TNF-α), endothelial injury, lipid deposition, etc. (Du et al. 2018). In conclusion, some authors 
claim that viral role is mainly to exacerbate the effects of bacterial infection, but their direct 





























 The main aim of the present study was to evaluate the changes occurring in the composition 
of the oral pathogenic microorganisms during aging and their impact on the presence of 
microorganisms in blood vessels of patients with atherosclerosis. 
 
 Specific aims were the following: 
 
1. To assess the epidemiological and sociodemographic characteristics of the patients with 
atherosclerosis;  
 
2. To determine the frequency of periodontal pathogens Porphyromonas  gingivalis, Prevotella 
intermedia, Tannerella forsythia, Treponema denticola and Аggregatibacter 
actinomycetemcomitans in the oral cavity and bloods vessels of patients with 
atherosclerosis;  
 
3. To compare the presence of microorganisms in younger versus older patients with 
atherosclerosis; 
 
4. To determine the frequency of periodontal pathogens Porphyromonas  gingivalis, Prevotella 
intermedia, Tannerella forsythia, Treponema denticola and Аggregatibacter 
actinomycetemcomitans  in thrombi of a limited number of patients with myocardial 
infarction; 
 
5. To compare the frequency of oral pathogens and human cytomegalovirus in atherosclerotic 





































3. MATERIALS AND METHODS 
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3.1. Patients 
The bulk of the study included a total of 100 patients with moderate to severe periodontal disease 
and atherosclerosis. Atherosclerosis was clinically diagnosed at the Clinic for Vascular and 
Endovascular Surgery at the Clinical Center Belgrade, and at the Institute for Cardiovascular 
Diseases KBC "Dr. Dragiša Mišović" Dedinje in Belgrade.  
 
A positive diagnosis of atherosclerosis was based on: 
 Clinical findings, 
 Coronary angiography, 
 Doppler echosonography 
 
Samples of atherosclerotic plaques obtained after vascular surgery were divided into six groups in 
relation to the localization of atherosclerotic blood vessel: 
 Group I: samples from carotid arteries (30), 
 Group II: samples of abdominal aortic aneurysm (10), 
 Group III: samples of femoral arteries (10), 
 Group IV: samples of iliac arteries (4), 
 Group V: samples of coronary arteries (33),  
 Group VI: mammary artery samples (13).  
 
In addition to general anamnestic data that included name, sex and age of the patients, the duration 
of the disease and the possible existence of predisposing factors were registered in the patients’ 
charts. Patients were examined in hospital conditions one day prior to scheduled surgery. 
Information on education and occupation (social status) and about life style (smoking, alcohol 
consumption and hygiene habits) were also collected. In the personal history, information about 
possible systemic diseases (hypertension hematological and endocrine diseases) was also sought. 
From family history information on the presence of family disorders (CVD, hypertension and 
diabetes mellitus type 2) was also obtained. 
Additionally, a small number of thrombi (13 in total) obtained from patients with myocardial 
infarction was included in the study and analyzed for the presence of oral pathogens and human 
CMV. 
 
3.2. Isolation of DNA  
For the detection of periodontal pathogens, bacterial DNA was isolated by treating the samples 
(both subgingival plaques obtained by paper points, and atherosclerotic plaques) with 10% 
proteinase K (MBI Fermentas, Vilnius, Lithuania) at 56°C for 30 minutes, followed by inactivation 
of the enzyme by heating the samples at 94°C for 15 minutes. DNA prepared in this way was stored 
at –20°C prior to PCR analysis.  
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3.3. Polymerase chain reaction analysis (PCR) 
The presence of oral pathogenic microorganisms in subgingival plaques, atheromas and thrombi of 
patients with atherosclerosis and myocardial infarction was determined by PCR method, using pairs 
of oligonucleotide primers specific for the given bacterial species.  
The standard PCR reaction consisted of the following steps (Figure 10): 
Denaturation: extracted DNA is heated, leading to separation of the double strand DNA 
molecule into two single DNA strands.   
Annealing: forward and reverse primers anneal to the complementary site at each of the 
single-stranded DNA templates. Melting temperature (Tm) of the primer pairs determines the 
annealing temperature.     
Extension or elongation: new complementary DNA strands are synthesized by elongation 
of the primers thanks to DNA polymerase enzyme.      
 




PCR reaction is carried out with automated thermal cycler with each reaction step at the precise 
temperature and for a defined duration. Generally, the procedure is repeated 30- 40 times. At the 
end, the reaction tube contains about 2
30 
molecules of the target PCR product. 
From subgingival plaques and atherosclerotic plaques from diseased blood vessels the presence of 
the following bacteria was investigated: Porphyromonas gingivalis, Tannarella forsythia, 
Agreggatibacter actinomycetemcomitans, Prevotella intermedia, and Treponema denticola. 
Positive controls were the following:  Porphyromonas gingivalis (ATCC 33277), Tannarella 
forsythia (ATCC 43037),  Agreggatibacter actinomycetemcomitans (ATCC 33384), Prevotella 
intermedia (ATCC 33563) and Treponenema denticola (ATCC 35405). 
PCR was performed in volumes of 25 µl containing 1X PCR buffer (MBI Fermentas), 1.5 mM of 
MgCl2, 0.2 mM dNTPs, 0.375 µM of each primer, 1 unit of Taq DNA polymerase (MBI 
Fermentas), and 5 µl of template DNA containing supernatant (Table1). The amplification was 
performed in a DNA thermal cycler (PeqStar; PeqLab, Erlangen, Germany) programmed at 95°C (3 
minutes), followed by a 35 cycle routine of 94°C (45 seconds), annealing temperatures appropriate 
for each primer pair (Table 2 and Figure 10) (1 minute), and extension at 72°C (1 minute), plus a 
final extension at 72°C (5 minutes).  
 
 
Table 1. Final concentrations/volumes of the PCR mixture 
Components Final concentration 
10 x PCR Buffer 1x 
25mM MgCL2 2.5 mM 
dNTP 200 µM 
Forward primer 0.2 µM 
Reverse primer 0.2 µM 
Taq polymerase 1 U 
DNA 4 µl 
Final volume 25 µl 
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7 minutes   
72°C 
denaturation hybridization extention 
1 min 1 min 1 min 
94°C 55-60°C 72°C 
 
Instead of DNA samples, water was used as a negative control for the PCR reactions. 
For each microorganism, the DNA obtained from the reference strain was used as the positive 
control. All primer sequences are listed in Table 3. 
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Table 3. Primer sequences, specific temperatures of hybridization and length of amplicons for the 
analyzed bacteria and human CMV 
Primer sequence 5’- 3’ Hybridization (С°) Length of 
PCR 
products 






Fwd  AGGCAGCTTGCCATACTGCG 
Rv  ACTGTTAGCAACTACCGATGT 






Fwd  GCTAATACCGCGTAGAGTCGG 
Rv  ATTTCACACCTCACTTAAAGGT 
T. forsytensis 
53 641 bp Fwd  GCGTATGTAACCTGCCCGCA 
Rv  TGCTTCAGTGTCAGTTATACCT 
P. intermedia 
53 259 bp Fwd CGTGGACCAAAGATTCATCGGTGGA 
Rv  CCGCTTTACTCCCCAACAAA 








Human cytomegalovirus     
OUT Fwd  CAGTTGACCGTACTGCAC 52 489 bp  
OUT Rv  GGTATCAAGCAAAAATCT 
In Fwd  GAAACGCGCGGCAATCGG 60 301 bp 
IN Rv  TGGAACTCGAACGTTTGG 
 




Thanks to the speed at which it is performed and its high resolution, polyacrylamide gel 
electrophoresis (PAGE) is one of the best methods used to separate and visualize nucleic acids. 
PAGE is based on the copolymerization of acrylamide and bisacrylamide (N-N'-methylene-
bisacrylamide). The polymerization is activated by adding TEMED (tetramethylethylenediamine) 
and APS (ammonium persulphate), the latter containing persulphate free radicals that activate 
TEMED and the polymerization itself.   
In our experiments, products of PCR amplification were mixed with loading buffer, which has a 
function to increase sample density, color the sample, and allow monitoring of electrophoresis. 
Electrophoresis was carried out on 8% gel in 1x TBE buffer at a constant voltage of 200V for 60 
minutes (Table 4). PCR products were illuminated with ultraviolet light, and according to the size 
of the amplified DNA sequence (band position on the gel) the product was identified (Figure 11). 
 
Table 4. Components of the polyacrilamide gel used for the visualization of PCR products. 
Water 3.9 ml 
5 x TBE 1.3 ml 
Acrylamide/ Bisacrylamide  30% 1.3 ml 
APS 10% 46 µl 
TEMED 8.4µl 
 
Figure 11. A representative gel showing products of amplification of T.denticola; the presence of 
band (lane 1 and 2) at around 300bp corresponds to the presence of bacteria in the sample; lane 
marked with * - positive control 
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3.5. Real-Time Quantitative PCR 
For the estimation of total bacterial load in the atherosclerotic plaques and thrombi we used a real-
time quantitative polymerase chain reaction method (qPCR). qPCR is a modification of PCR, 
introduced by Higuchi and coworkers in 1992. It enables exact quantification of specific nucleic 
acids in a complex mixture even if the starting amount of material is at a very low concentration. 
Real-time qPCR has become widely used in genotyping analyses, the quantification of viral load in 
patients, and the estimation of gene copy number in cancer tissue. However, this technology is most 
commonly used to study gene expression levels by coupling it with the reverse transcription-PCR 
(RT-PCR) (Fraga et al. 2014; Ginzinger 2002).
 
 
The basic principle of qPCR is that as short DNA sequences are copied at each cycle, the amount of 
DNA in the reaction doubles, resulting in an exponential amplification of the initial target during 
the early cycles, when the PCR components are largely available compared to the target sequence. 
But, as product accumulates, the substrates are reduced, resulting in the inhibition of the reaction 
(Fraga et al. 2014; Valasek & Repa 2005).  
The qPCR reaction can be broken into three distinct phases: exponential, linear, and plateau. The 
first phase of the reaction is the exponential phase, when the reaction is progressing with 100% 
efficiency and with product doubling at each cycle. Sometimes attaining 100% efficiency is not 
possible and careful optimization of PCR conditions must be conducted to ensure that reactions are 
proceeding as efficiently as possible (Fraga et al. 2014; Guide 2016). While the amplicon 
continuously accumulates, the PCR ingredients are consumed, the primer starts competing with 
amplicon reannealing to itself, and the reaction capability decreases. Over time, the reaction slows 
down and enters the second phase, the linear or non-exponential phase. Because of further 
substrates reduction and product inhibition, the reaction will slow down and enter the plateau 
phase. Figure 12 represents the three real-time PCR reaction phases and the variations of these 











Figure 12. PCR reaction phases, the x axis: cycle number, y axis: amount of DNA 
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Real-time qPCR measures the amount of amplicon produced during each amplification cycle using 
fluorescence-based technology and can quantify amplicon production at the exponential phase or 
the beginning of the linear phase of the PCR reaction, in contrast to measuring the amount of 
product at the end-point of the reaction. The amplification reaction is monitored by labeling the 
accumulating product with a fluorescent reporter molecule, such as a double-stranded DNA-binding 
dye. The typical DNA-binding dyes are SYBR Green I and EvaGreen®. When such dyes are free in 
solution, they display comparatively low fluorescence, but when bound to double-stranded DNA, 
their fluorescence increases by over 1000-fold. As the double-stranded DNA increases, the dye 
binding sites will increase. This dye property provides the mechanism that allows it to be used to 
track the PCR product accumulation.  
As the target DNA is amplified, its increasing concentration in the solution is directly proportional 
to the fluorescence and can be directly measured by the increase in fluorescence signal; with the 
qPCR instrument system, the data for each sample during each PCR cycle will be collected. The 
resulting plots of fluorescence vs. cycle number for all the samples are then set with their 
background fluorescence at a common starting point (a process known as baseline correction). 
Then, a threshold level of fluorescence is set above the background but still within the lower part of 
the linear phase of amplification for all the plots. The cycle number where the amplification plot 
crosses this threshold, is called the “Ct” or cycle threshold. This Ct value can be directly related to 
the starting target concentration of the sample. The greater initial DNA template amount in the 
sample, the Ct value for that sample will be reached earlier (Fraga et al. 2014; Guide 2016; Arya 
et al. 2005). The results are calculated as “relative quantity to the calibrator”, where the calibrator 
sample is assigned an arbitrary quantity of “1” and all the other samples are expressed in terms of 
their fold difference to this sample.  
The earliest approximation method of comparative quantitation (∆∆Ct) is used for this purpose. It 




Relative quantity to the calibrator = 2
-(ΔΔCt) 
 
Where ∆∆Ct = (CtGOI – Ctnorm) unknown – (CtGOI – Ctnorm) calibrator 
 
GOI refer to the gene of interest (tested gene), norm refers to the reference gene (or normalizer)  
 









Figure 13. The calculation of ∆Ct using ∆∆Ct method; ∆Ct is determined by calculating the 
difference between the Ct of the normalizer and Ct of the GOI for each sample 
(https://pdfs.semanticscholar.org/4a6e/f96ee80979ad3c7799ced161dba37be6c47f.pdf) 
 
In our real-time PCR experiments, reaction mixture (25µl) contained 5 µl of bacterial DNA sample, 
12.5 µl of Maxima™ SYBR Green/ROX qPCR Master Mix (Thermo Fisher Scientific, Vilnius, 
Lithuania), 1 µl of EuF and EuR primers at the final concentration of 0.2 µM and 5.5 µl of water. 
The universal primers EuF 5’TCCTACGGGAGCACAGT3’ and EuR 
5’GGACTACCAGGGTATCTAATCCTGTT3’ (Nadkarni et al. 2002) (Thermo Fisher Scientific, 
Vilnius, Lithuania) target highly conserved 16S rDNA region.  
Real-time PCR analyses were performed on Line Gene-K Fluorescence Real-time PCR Detection 
System (BIOER Technology, Shanghai, China) under following conditions: initial denaturation at 
94 °C for 10 minutes; 40 cycles of denaturation at 94 °C for 1 minute, annealing at 60 °C for 1 
minute and elongation at 72 °C for 1.5 minutes; and terminal elongation at 72 °C for 5 minutes. 
qPCR experiments for all samples were performed in duplicate. 
A series of ten-fold diluted reference DNA samples (Prevotella melaninogenica strain ATCC 
25845: 32.4 fg – 32.4 ng) was included in each run in order to generate standard curve. The total 
bacterial gene copy number was determined by interpolation on the standard curve, as previously 




3.6. Statistical analyses  
The methods of descriptive statistics, such as measures of central tendencies, were used to describe 
the results of the study. The Chi square test was carried out to compare basic epidemiological and 
clinical characteristics, as well as the prevalence of periopathogenic bacteria between examined 
groups. A p-value lower than 0.05 was considered statistically significant. All statistical analyses 
were performed on Statistical Package for the Social Sciences software, version 22.0 (IBM SPSS 















































4.1. Sociodemographic characteristics of patients 
4.1.1. Age, gender and lifestyle 
The study covered 100 subjects with moderate to severe periodontal disease and atherosclerosis: 69 
male (69%) and 31 female (31%). None of the subjects had been treated with antibiotics in the last 
3 months nor had received periodontal treatment in the previous 6 months.  
The average age of the subjects was 59.2 years. The youngest participant was 28 years old and the 
oldest 94 years old (Table 5).  
 
Table 5. Age and sex of participants 














Patients were divided into six groups in relation to the localization of atherosclerosis and into two 
groups in relation to their age; 28-60 ( in total 52, out of which 8 patients were in the group 28-40 
years, 17 in the group 41-50 years and 27 in the group 51-60 years) and 61-94 (48 in total, out of 
which 32 patients were in the group 61-70, 13 in the group 71-80 years, 2 in the group 81-90 years 
and 1 in the group 91-94 years). The distribution of patients’ age in relation to the blood vessel that 
was atherosclerotic is given in Table 6, and no statistically significant difference could be 
established among them. 
Table 6. Atherosclerotic blood vessels in relation to age 
Blood vessel N
o
 x  SD Med Min Max 
Carotid artery 30 61.8 12.1 63.0 28 94 
Abdominal artery 10 61.0 7.0 61.5 50 70 
Femoral artery 10 55.4 13.4 60.0 32 72 
Iliac artery 4 68.0 17.5 69.5 47 86 
Coronary artery 33 56.6 13.3 55.0 32 83 
Mammary artery 13 57.8 14.8 54.5 42 77 
N
o
- number, x - average, SD - standard deviation, Med - median, Min - minimum value, Max - maximum 
value 
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Samples of subgingival plaques and atherosclerotic plaques removed from the diseased blood 
vessels were examined for the presence of the following bacteria: Porphyromonas gingivalis, 
Tannarella forsythia, Agreggatibacter actinomycetemcomitans, Prevotella intermedia and 
Treponema denticola.  
As much as 91% of oral samples were positive for at least one of the tested microorganisms, while 
in the group of atherosclerotic plaque samples 69% were positive. In subjects with intra-orally 
present periopathogenic bacteria the average age was 58.8 years, and in subjects with both intra- 
and extra-orally isolated microorganisms the average age was 59.6 years (p>0.05). The average age 
of subjects with non-isolated microorganisms was 57.3 years.  
The majority of participants had secondary education (63%); highly educated participants had a 
frequency of 24%, while the lowest percentage of participants was with elementary education 
(13%). No correlation could be established between education and microorganism presence. 
More than half of the participants (58%) were smokers, and their distribution in relation to the 
blood vessels affected by atherosclerosis is given in Table 7.  
 
Table 7. Smoking status in relation to blood vessels affected by atherosclerosis 
Blood vessel 
Smoking 
Yes (%) No (%) 
Carotid artery 76.0 24.0 
Abdominal artery 60.0 40.0 
Femoral artery 60.0 40.0 
Iliac artery 50.0 50.0 
Coronary artery 35.0 65.0 
Mammary artery 75.0 25.0 
Total 58.0 42.0 
 
 
The incidence of smokers in patients with intra-oral and extra-oral microorganisms was 56.5%, 
while the incidence rate was slightly lower in patients with only intra-oral microorganisms (55%). 
Interestingly, the highest incidence of smokers was in the group of patients without detected 
microorganisms (75%). The frequency of smokers did not differ statistically from non-smokers 
regarding the presence of microorganisms in the blood vessels (p = 0.583).  
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Alcohol consumption was less represented; only 28% of patients reported that they consumed 
alcohol and their distribution in relation to the blood vessels affected by atherosclerosis is 
summarized in Table 8.  
 




Yes (%) No (%) 
Carotid artery 38.0 62.0 
Abdominal artery 40.0 60.0 
Femoral artery 10.0 90.0 
Iliac artery 25.0 75.0 
Coronary artery 17.0 83.0 
Mammary artery 38.0 62.0 
Total 28.0 72.0 
 
 
The frequency of alcohol consumption in subjects without microorganisms was 25%, with intra-
oral bacteria 30%, and with both intra-oral and extra-oral bacteria 27%. The frequency of alcohol 








Just under half of the participants had a good level of oral hygiene (47%), while 53% of the subjects 
had poor oral hygiene. The distribution of patients with good or poor oral hygiene depending on the 
blood vessel affected by atherosclerosis is given in Table 9. 
 
Table 9.  Oral hygiene among patients with different blood vessels affected by atherosclerosis 
Blood vessel 
Level of hygiene 
Good (%) Poor (%) 
Carotid artery 31.0 69.0 
Abdominal artery 40.0 60.0 
Femoral artery 50.0 50.0 
Iliac artery 50.0 50.0 
Coronary artery 59.0 41.0 
Mammary artery 62.0 38.0 
Total 47.0 53.0 
 
The frequency of good oral hygiene in subjects without microorganisms was 50%, with intra-oral 
microorganisms 55%, and with intra-oral and extra-oral bacteria 44%. The frequency of good oral 
hygiene did not differ statistically between the groups. 
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4.1.2. Personal history of diseases 
 
Sixty six percent of the participants had been diagnozed with hypertension, and their distribution in 
relation to the blood vessels affected by atherosclerosisis is given in Table 10. Although a vast 
variation in the frequency of hypertension was evident (from 100% in the group with iliac artery 
atherosclerosis to only 30% in the group of femoral artery atherosclerosis), statistically significant 
difference between the groups could not be confirmed.   
 
Table 10. Hypertension and type of blood vessel affected by atherosclerosis 
Blood vessel 
Hypertension 
Yes (%) No (%) 
Carotid artery 72.0 28.0 
Abdominal artery 70.0 30.0 
Femoral artery 30.0 70.0 
Iliac artery 100.0 0.0 
Coronary artery 62.0 38.0 
Mammary artery 75.0 25.0 
Total 66.0 34.0 
 
Hypertension in the personal history of the subjects was the least represented in the group of 
patients without microorganisms. The frequency of hypertension in these subjects was 37%, with 
intra-oral microorganisms only 65%, and with both intra-oral and extra-oral bacteria it was 69%. 
The frequency of hypertension did not differ statistically between the groups (P=0.205).  
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The incidence of endocrine diseases in personal history was the lowest in the group of 
patients without microorganisms, 25%, followed by 30% in subjects with intraoral findings of 
microorganisms and, finally in subjects with intraoral and extraoral bacteria, it was slightly higher 
(32%.). Their distribution according to affected blood vessels is given in Table 11. 
 




Yes (%) No (%) 
Carotid artery 34.0 66.0 
Abdominal artery 40.0 30.0 
Femoral artery 25.0 75.0 
Iliac artery 25.0 75.0 
Coronary artery 21.0 79.0 
Mammary artery 50.0 50.0 
Total 33.0 67.0 
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Haematological and immunological diseases in personal history were present only in the 
group of subjects with intraoral and extraoral findings of microorganisms, in 10% of patients. 
 
Table 12. Hematological and immunological diseases in personal history and type of blood vessel 
affected by atherosclerosis 
Blood vessel 
Hematological and immunological diseases 
Yes (%) No (%) 
Carotid artery 30.0 70.0 
Abdominal artery 20.0 80.0 
Femoral artery 0.0 100.0 
Iliac artery 0.0 100.0 
Coronary artery 3.0 97.0 
Mammary artery 0.0 100.0 
Total 6.0 94.0 
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4.1.3. Familial history of diseases 
 
Data about medical history in the family of the patients are given in Tables 13 (cardiovascular 
disease) and 14 (diabetes mellitus).  
Sixty seven and forty percent of patients had a familly history of cardiovascular diseases and 
diabetes mellitus, respectively. The family history of cardiovascular disease varied from 50% in the 
group with iliac artery atherosclerosis, to as high as 83% in the group with carotid artery 
atherosclerosis. Diabetes mellitus was less represented in the family history: from 24% in patients 
with coronary artery atherosclerosis, to 55% in patients with carotid artery atherosclerosis. 
However, there were no statistical differences in the incidences of positive family history in relation 
to the blood vessels affected by atherosclerosisis.  
 
 
Table 13. Presence of cardiovascular diseases in the families of patients with different blood 
























Cardiovascular disease in the family 
Yes (%) No (%) 
Carotid artery 83.0 17.0 
Abdominal artery 70.0 30.0 
Femoral artery 70.0 30.0 
Iliac artery 50.0 50.0 
Coronary artery 52.0 48.0 
Mammary artery 62.0 38.0 
Total 67.0 33.0 
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Table 14. Presence of diabetes mellitus type II in the families of patients with 






































Diabetes mellitus type II in the family 
Yes (%) No (%) 
Carotid artery 55.0 45.0 
Abdominal artery 40.0 60.0 
Femoral artery 30.0 70.0 
Iliac artery 50.0 50.0 
Coronary artery 24.0 76.0 
Mammary artery 50.0 50.0 




When epidemiologic data were compared based on patients age, as expected, the two age groups 
with periodontal disease and atherosclerosis showed a statistically significant difference in regard to 
the incidence of hypertension, diabetes and family history of cardiovascular diseases (Figure 14). 
All risk factors for development of cardiovascular diseases were more frequent in the group of older 
patients, and all of them, except smoking, differed statistically between the two groups.  
 
 
Figure 14. Basic epidemiological and clinical characteristics of the two age groups of patients 
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4.2. Oral bacteria distribution in the oral cavity and in blood vessels  
As already mentioned, 65% of samples of atherosclerotic arteries and 91% of oral samples were 
positive for at least one of the tested microorganisms. The decreasing frequencies of 
microorganisms in oral specimens versus artery specimens in the entire patient group, regardless of 
their age, were as follows: T. forsythia (76% vs. 53%), P. intermedia (71% vs. 31%), P. gingivalis 
(60% vs. 38%), A. actinomycetemcomitans (39% vs. 14%) and T. denticola (21% vs. 6%). The 
distributions of microorganisms in subgingival and atheromatous plaques are given in Figure 15. 
Figure 15.  Comparison of microorganisms’ incidence in subgingival versus atherosclerotic plaques 
in the entire sample, regardless of patients’ age 
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The ratio of subgingival versus artery bacteria was as follows: T. forsythia 1.4, P. gingivalis 1.6, P. 
intermedia 2.3, A. actinomycetemcomitans 2.8 and T. denticola 3.5. 
Coronary arteries were the blood vessels in which microorganisms were most frequently found, 
followed by carotid, abdominal and mammary arteries. Oral pathogens were rare in femoral and 
could not be detected at all in iliac arteries (Figure 16).  
 
 
Td: T. denticola; Aa: A. actinomycetemcomitans;  
Pg: P. gingivalis; Pi: P. intermedia; Tf: T. forsythia 
 
 




When focusing on bacterial incidence changes in artery samples in relation to the patients’ age, 
statistically significant difference between younger and older patients were found only for P. 




Pg: P. gingivalis; Aa: A. actinomycetemcomitans; 
Tf: T. forsythia; Td: T. denticola; Pi: P. intermedia 
Figure 17.  Microorganism incidence in arteries of patients below 60 and over 60 with 
atherosclerosis 
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Differences between younger and older patients were also noted when considering the number of 
different bacterial species per blood vessel, but without reaching statistical significance (Figure 18). 
 
 
Figure 18. Percentage of artery samples with 0, 1, 2, 3, 4 or 5 different bacterial species in relation 
to patients’ age  
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When comparing the incidence of bacteria in oral specimens versus blood vessels specimens in 
relation to patients’ age, it appears that the relationships are not dramatically changed (Figure 19). 
 
Figure 19. Prevalence of periopathogenic bacteria in subgingival and atherosclerotic plaque 
samples of younger and older patients; Tf: T. forsythia; Pi: P. intermedia; Pg: P. gingivalis; Aa: A. 




4.3. Oral bacteria distribution in thrombi 
Only a small number of thrombi were available for the study. Six samples were obtained from 
patients with myocardial infarction, undergoing catheterization for blood clot removal, while seven 
samples were obtained from cadavers. In the latter case, samples of atherosclerotic blood vessel and 
thrombus could be obtained from the same donor, i.e. it was possible to compare the bacterial 
content in the two types of specimens. This possibility was used not only for qualitative, but also 
for quantitative comparison of bacterial communities’ composition. 
When seven atheromas and seven thrombi obtained from cadaver samples were compared, it 
appeared that bacterial content in thrombi was statistically lower than the content in atheromas 
(Figures 20 and 21). 
 














Figure 21. Quantitative analysis of total bacterial content in atheromas versus thrombi 
 
When freshly taken thrombi were also included in the analysis, the picture looked different (Figure 
22). Namely, in the fresh thrombi, obviously a higher bacterial content was present. 
 
 




4.4. Qualitative analysis of oral pathogens and human CMV in atheromas versus thrombi 
When comparative analysis of paired atheroma-thrombus samples (from 7 cadavers) was done, it 
appeared that some bacteria could not be detected at all in thrombi, while some others (P. 
gingivalis) were found only in thrombi (Figure 23). 
 
 
Figure 23.  Comparative analysis of bacterial species in atheromas and thrombi in cadaver samples 
Aa: A. actinomycetemcomitans; Pi: P. intermedia; Tf: T. forsythia; Td: T. denticola; Pg: P. gingivalis 
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The detection of human CMV was also done on a relatively small number of atheromas, in total 23 
(16 specimens from patients and 7 specimens from cadavers) and thrombi (13). The results of 
qualitative analysis for both bacteria and human CMV are given in Figure 24. From this limited 
analysis it appeared that human CMV was more frequently found in blood clots than in blood 
vessels, but due to the small sample size, no statistically significant difference could be established. 
 
 
Figure 24. Comparative analysis of bacterial species and human CMV found in a limited number of 
samples; Tf: T. forsythia; Aa: A. actinomycetemcomitans; Pi: P. intermedia; Td: T. denticola; Pg: P. 
































The fundamental role of infection and inflammation in the initiation and progression of 
atherosclerosis is now widely accepte (Seymour et al. 2007; 2009; Miettinen et al. 1996). It must 
be emphasized that up to 50% of people with CVD, have none of the classic risk factors, such as 
smoking and alcohol consumption, obesity, high blood pressure and diabetes, implicating that some 
risk/etiologic factors are still missing. If the problem of high CVD morbidity and mortality has to 
be tackled, it is essential to uncover all possible risk factors and target all those that are modifiable.  
In the last two decades, the cause-effect association between periodontal disease and CVD has been 
thoroughly assessed (Inaba & Amano, 2010; Hujoel et al. 2001). Namely, it was established that 
the risk of developing atherosclerosis and myocardial infarction was significantly increased in 
individuals with severe chronic periodontitis, the most prevalent chronic infection and 
inflammatory disease in humans worldwide (Seymour et al. 2007; Valtonen, 1999; Seymour et 
al. 2007; 2009).
 
Given that over the past 50 years, there has been a substantial increase in the 
number of people retaining more of their teeth, this increasingly dentate population will be at even 
greater risk for periodontal and cardiovascular diseases. 
With the present study we aimed at bringing additional information to the complex relationship 
between periodontal disease and cardiovascular disease, in particular atherosclerosis. The bulk of 
our study was focused on 100 patients with moderate to severe periodontal disease and 
atherosclerosis. Atherosclerosis was clinically diagnosed at the Clinic for Vascular and 
Endovascular Surgery at the Clinical Center Belgrade and at the Institute for Cardiovascular 
Diseases KBC "Dr Dragiša Mišović" Dedinje in Belgrade. A positive diagnosis was based on 
clinical findings, coronary angiography and Doppler echosonography. Periodontal disease was 
diagnosed by routine dental examination. Patients were divided into six groups in relation to the 
localization of atherosclerosis and into two groups in relation to their age.  
Anamnestic and epidemiological analyses showed the following results: there was no statistically 
significant difference regarding the median age of patients who had different blood vessels affected 
by atherosclerosis. The highest age span was found among patients with atherosclerosis of carotid 
arteries. The lowest median age of 54.5 years was established in the group of patients with 
atherosclerosis of mammary arteries, while the highest was in the group of patients with 
atherosclerosis of iliac artery (69.5 years). Generally, literature data report on huge variations of the 
mean age of patients affected by atherosclerosis, depending on patients’ ethnical background and 
whether they live in high or low income countries, as thoroughly stressed in the Introduction 
section. 
The majority of our patients had a secondary degree of education, which is in agreement with 
epidemiological data presented in some other studies on atherosclerosis and CVD (Eng et al. 2015), 
but this relatively high level of education had no impact on oral pathogenic microorganisms’ 
presence.  
No statistically significant difference was noted between the smoking status of patients belonging to 
different study subgroups, nor could a difference be established between smokers and non-smokers 
in terms of microorganisms’ presence. Some authors indicated smoking as a significant 
confounding factor influencing the seemingly present association between periodontitis and CVD 
(Chukkapalli et al. 2015; Hujoel et al. 2002). This is supported by analyses which include 
adjustments for some smoking-related variables such as the number of cigarettes per year, time after 
stopping to smoke, passive smoking, etc. (Chukkapalli et al. 2015; Nasry et al. 2006; Costa et al. 
2013). However, association between periodontitis and CVD was also recurrently described in 
studies on never-smokers (Chukkapalli et al. 2015; Okoro et al. 2005), leaving this question 
opened for future analyses.  
Similarly, no consistent association could be established between the presence of microorganisms 
and alcohol consumption in the different study subgroups. This can be explained, either by the 
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small sample size, or by the fact that patients’ answers, especially with regard to questions about 
drinking, are not reliable. And again, no correlation was found between different groups regarding 
oral hygiene.  
There was a huge variation in the frequency of hypertension in patients with different blood vessels 
affected by atherosclerosis (from 100% of hypertensive patients in the group with iliac artery 
atherosclerosis to only 30% of hypertensive patients in the group of femoral artery atherosclerosis), 
but without statistically significant difference, between the groups. The majority of patients had a 
family history of cardiovascular disease (from 50% in the group with iliac artery atherosclerosis, to 
83% in the group with carotid artery atherosclerosis). Diabetes mellitus was less represented in the 
family history (from 24% in patients with coronary artery atherosclerosis, to 55% in patients with 
carotid artery atherosclerosis). It must be emphasized that there is a bidirectional relationship 
between periodontitis and systemic diseases, i.e. patients with some systemic disease, such as CVD 
or diabetes are more prone to periodontitis and often the cause-effect is not easy to establish. The 
influence of diabetes mellitus on periodontal disease is not fully explored yet. Some studies in 
adults have found no association between periodontal disease and diabetes. On the other hand, some 
have shown an increased susceptibility to periodontal disease in adults with diabetes mellitus 
(Thorstensson & Hugoson 1993). In other words, the complex relationship existing between 
CVD/diabetes and periodontal disease needs further clarifications. 
When the two age groups were taken into consideration, regardless of the affected artery, a 
statistically significant difference appeared in the frequency of hypertension and family history of 
cardiovascular disease, “in favor” of the older age group, which was a rather expected finding.  
The relationship between periodontal disease and CVD is influenced by age, with a stronger 
association in patients below 60-65 yrs compared to patients 60-65 (Chukkapalli et al. 2015; Sim 
et al. 2008). At the same time, it was also established that individuals with treated periodontal 
disease older than 60 years have increased risk of long-term detrimental cardiovascular events 
compared with subjects below 60 years. The association remained after adjustment for other 
potential CVD-related confounders such as gender, hypertension, diabetes and hyperlipidemia 
(Chukkapalli et al. 2015; Chou et al. 2015).  
In the present study, as much as 91% of subgingival plaques tested positive for the studied 
microorganisms, while 65% of atherosclerotic arteries were positive for at least one of the oral 
pathogens. These findings support the idea that periodontal pathogens enter the circulation, causing 
transient bacteremia, and then lodge in diseased blood vessel walls.  
The PCR analysis of both oral cavity and atherosclerotic blood vessels’ tissue samples showed a 
high prevalence of the following oral pathogens: Porphyromonas gingivalis, Prevotella intermedia, 
Tannerella forsythia, Treponema denticola and Аggregatibacter actinomycetemcomitans. This 
result is in general agreement with a number of previous reports dealing with periodontal disease 
and atherosclerosis (Pucar et al. 2007; Kebschull et al. 2010; Bartova et al. 2014; Hussain et al. 
2015; Bale et al. 2016).  
The most prevalent bacterium in both oral and blood vessel samples was T. forsythia, and the least 
prevalent was T. denticola. The decreasing frequencies of microorganisms in oral specimens were: 
T. forsythia (76%), P. intermedia (71%), P. gingivalis (60%), A. actinomycetemcomitans (39%) and 
T. denticola (21%), whereas in atherotic samples the frequencies were lower and the decreasing 
order was somewhat different compared to the oral cavity: T. forsythia (53%), P. gingivalis (38%), 
P. intermedia (31%), A. actinomycetemcomitans (14%) and T. denticola (6%). Although there is a 
consensus regarding the most prevalent pathogenic microorganisms detected both in subgingival 
and atheromatous plaque, the rate of their detection (presence) may vary considerably from one 
study to another. For instance, Mahendra et al. reported the following incidence of bacteria, rather 
opposite to ours (in the subgingival and atheroma plaque): T. denticola 66% and 51%, P. gingivalis 
53 
64% and 45%, T. forsythia 43% and 31%, P. intermedia 27% and 23%, A. actinomycetemcomitans 
2% and 0% (Mahendra et al, 2015). In the study of Zaremba et al. (2007), P. gingivalis and T. 
denticola were the two most frequently detected microorganisms. Interestingly, in the study of 
Romano et al. percentages of bacteria similar to ours were determined in oral samples, but these 
authors did not detect the presence of any of the five microorganisms in 21 atheromas (Romano et 
al. 2007).   
A noteworthy finding of the present study was that different bacteria showed different affinity for 
blood vessel colonization (or different capacity to invade them). Namely, as judged from the ratio 
of bacteria present in the subgingival plaque versus bacteria in the arteries, it appeared that T. 
forsythia had the highest propensity to colonize artery walls, while T. denticola had the lowest. This 
ratio for different bacteria was the following: T. forsythia 1.4, P. gingivalis 1.6, P. intermedia 2.3, 
A. actinomycetemcomitans 2.8 and T. denticola 3.5 (Kannosh et al. 2018). 
Regarding the process of aging and it’s rather expected effects on bacteria distribution, only the 
incidence of P. gingivalis increased in arteries with patients’ age. T. denticola and T. forsythensis 
incidence remained unchanged, while the incidence of A. actinomycetemcomitans and P. intermedia 
showed a statistically significant decrease in the older group of patients. A comparable decrease for 
A. actinomycetemcomitans with aging has been previously described (Andjelkovic et al. 2017). 
When considering blood vessels in relation to their susceptibility to be colonized, coronary arteries 
were the blood vessels in which microorganisms were most frequently found, followed by carotid, 
abdominal and mammary arteries. Oral pathogens were rare in femoral and could not be detected at 
all in illiac arteries. This indicates that bacterial colonization mirrors the distance of a given artery 
from the mouth, which is the primary bacterial reservoir. Again, in the literature a remarkable 
heterogeneity of results can be found. For instance, Szulc et al. found P. gingivalis in less than 10% 
of coronary arteries, while in the carotid arteries almost 50% of their samples were positive for this 
microorganism (Szulc et al. 2015). Pucar et al., on the contrary found 53% of coronary arteries to 
be positive for the presence of P. gingivalis, 27% positive for A. actinomycetemcomitans, 33% 
positive for P. intermedia and 13% for T. forsythensis. Interestingly in their study 0% of mammary 
arteries were affected by oral pathogens, a finding that is in contrast with our results. They also 
detected a high percentage of CMV in their samples (67%), which was not the case in the present 
study in which only 17% of atheromas were positive (Pucar et al, 2007). Taylor-Robinson et al 
found oral bacteria in specimens from the iliac, mammary and coronary arteries and aorta, but the 
incidence of oral pathogens was rather low. They found approximately 20% of specimens to be 
positive for A. actinomycetemcomitans and only 9% for P. intermedia. Different data were obtained 
by Haraszthy et al: 30% of the surgical specimens were positive for B. forsythia, 26% for P. 
gingivalis, 18% for A. actinomycetemcomitans, and 14% for P. intermedia. In the atheromas 
positive for periodontal pathogens, more than one species were most often detected (59%), a 
finding close to ours (Haraszthy et al. 2000). This group however found a higher percentage of 
human CMV (38%) in their atheroma samples than we did (17%). In a very recent study, statistical 
difference was observed for the prevalence of 16S rRNA of P. gingivalis, T. forsythia, T. denticola 
and P. nigrescens both in subgingival and atheroma plaque of patients with ischemic heart disease 
compared to controls. In addition, co-occurrence of nine different bacteria in subgingival and 
atheroma plaque was observed in patients with ischemic heart disease. A similar co-occurrence was 
not seen in patients with chronic periodontitis but without systemic disease. The authors concluded 
that their study correlates periodontal bacterial co-occurrence to atherosclerosis” (Mahalakshmi et 
al. 2017).  
Similarly to data related to the incidence of periopathogenic bacteria, important variations of human 
CMV detection in blood vessels of patients with atherosclerosis were also noted. In the Chinese 
Han population, 60% of patients with carotid atherosclerosis and stroke were positive for HCMV, 
when PCR was used (Yi et al. 2008). The same group found lower levels of viral infection when 
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applying other techniques (34% found by immunohistochemistry and 40% found by in situ 
hybridization). Virok et al found human CMV in 50% of their carotid samples, either alone or in 
combination with Chlamydia pneumoniae (Virok et al. 2006). Pucar et al also detected a high 
percentage of CMV in their samples (67%), which was not the case in the present study in which 
only 17% of atheromas were positive (Pucar et al. 2007). Haraszthy et al, in a group of Hungarian 
patients with atherosclerosis, detected human CMV in 38% of their atheroma samples (Haraszthy 
et al, 2000). On the other hand, Tremolada et al did not find CMV nor SV1 in any of their 17 
samples of atherosclerotic plaques of carotid arteries (Tremoladai et al. 2011). A recent meta-
analysis, involving 30 studies and 3228 patients with atherosclerosis, showed the presence of viral 
DNA in 34% of cases (Jia et al. 2017). The authors concluded that human CMV is significantly 
related to increased risk of atherosclerosis.  
In the present study, human CMV was also assessed in thrombi of patients with myocardial 
infarction and in this specific biological material a much higher percentage of the virus was 
detected than in atheromas. Namely, 50% of thrombi contained CMV. This finding is in line with 
the evidence that acute-phase HCMV infection is related to thrombogenesis and thrombosis 
(Rahbar and Söderberg-Nauclér, 2005). Infected endothelial cells, a reservoir of CMV, recruit 
naive monocytes from the blood stream and allow virus transfer to migrating monocytes, which will 
lead to its dissemination. At the same time the virus will enhance the expression of endothelial 
adhesion molecules and thrombin production, resulting in clotting impairment (Popovic et al. 
2012).  
Besides social, geographical and ethnical explanations for the huge data variations, one must also 
take into consideration the possibility that the methodology used for bacteria detection might 
influence the accuracy of the findings and, importantly, the biological material used for oral 
pathogen detection, as well. Two main techniques are usually applied: cultures and PCR. PCR is 
considered to be the technique of choice for overcoming the restrictions related to culturing bacteria 
in terms of rapidity and sensitivity, since even one copy of the DNA target present in the clinical 
specimen can be identified (Sanz et al. 2004). PCR primers directed against conserved regions in 
the 16S rRNA gene are designed to specifically amplify either Gram-positive or Gram-negative 
bacteria; therefore, under appropriate conditions, PCR also exhibits very high specificity and has a 
superior performance compared with classical microbiological approaches (Santos et al. 2004). 
 
Standard diagnosis of bacterial infection, which depends on bacteria growth in culture, usually 
requires at least 12 to 72 h for detection and many anaerobes are difficult to grow. Molecular 
genetics methods for bacterial DNA detection are much faster and have shown great efficacy and 
sensitivity (greater than immunostaining). In particular, they are very useful for detection of strictly 
anaerobic bacteria. Even if the samples contain dead bacteria, PCR can still be applied as cell 
viability is not an imperative, i.e. because bacterial DNA is still in the sample (Garibyan & 
Avashia, 2013). There are also different variants of conventional PCR that are used in fundamental 




DNA microarray analysis is used for a fast 
semi-quantitative analysis of the main periodontal pathogens (Topcuoglu & Kulekci, 2015). 
Another technique, called viability PCR or vPCR, relies on cell viability and cell envelope 
impermeability (Nocker & Camper, 2008). In this method propidium monoazide is added in the 
PCR mixture. This substance selectively enters dead bacteria, intercalates with their DNA and 
consequently blocks PCR. Therefore, only microorganisms that are alive will be detected. In 
addition, another matter of debate is which type of sample is the best and most convenient to use in 
order to get reliable information regarding the presence of oral pathogens (buccal swabs, saliva, 
subgingival/supragingival plaque). In their study Sakamoto et al compared two types of samples 
(saliva and subgingival plaque samples) and three methods (cell culture, conventional PCR and 
qPCR) for the identification and quantification of periodontal microorganisms. The results indicated 
that saliva in combination with qPCR gave good results regarding the detection and quantification 
of periodontal bacteria in the oral cavity (Sakamoto et al. 2001).  
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Although all PCR based techniques have some limitations, with the possibility, although remote, of 
contaminations, cross-reactions, false positive results, false negative results, etc., they undeniably 
revolutionized our knowledge on periodontal pathogens (Kotsilkov et al. 2015). Recently, 
commercial diagnostic tests using multiplex PCR (e.g., MyPerioPath®, MicroDent® Test, etc.) 
have been introduced for the assessment of microorganisms in subgingival plaque samples, 
allowing for a better prevention program and the development of individualized treatment (Do, 
Devine & Marsh 2013).  
In conclusion, our results support the idea that exposure to periodontal microorganisms and 
concomitant inflammation play a role in the etiology of atherosclerosis and myocardial infarction. 
However, it must be emphasized that our study covered only one point in time. Therefore, in order 
to more accurately perceive the role of periodontal pathogens in the development of those diseases, 
precise measurements of the intensity of periodontal disease, frequency and length of bacteremia 
and duration of exposure to inflammatory mediators coming from the periodontium, all in a wider 








































 Oral pathogenic bacteria were abundant in both subgingival plaque and blood vessels of 
patients with atherosclerosis, with an overall ratio of 91% versus 65% in the two types of 
samples 
 
 The most prevalent bacteria in both types of biological samples was T. forsythia and the 
least prevalent was T. denticola 
 
 With aging, the incidence of bacteria changed slightly. The decreasing order of bacterial 
incidence in younger patients was the following: T. forsythia > P. intermedia > P. gingivalis 
> A. actinomycetemcomitans > T. denticola while in the elderly patients it was: T. forsythia 
> P. gingivalis > P. intermedia > A. actinomycetemcomitans > T. denticola 
 
 Interestingly, there was no statistically significant difference in the total incidence of 
microorganisms between the two age groups 
 
 The decreasing order of atherosclerotic bloods vessels according to incidence of oral 
pathogens was the following: coronary artery > carotid artery > abdominal artery > 
mammary artery > femoral artery > iliac artery 
 
 Bacterial quantification performed in a limited number of samples showed that there was no 
significant difference in the total bacterial content between thrombi and atheromas  
 
 The qualitative analysis, however showed slight differences in the presence of different 
bacterial species 
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